Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
InSitu Biologics
AddedFeb 15, 2024
UpdatedJun 18, 2026
InSitu Biologics

InSitu Biologics

Series A

InSitu Biologics: An emerging biotech firm developing a prolonged-release drug delivery platform.

HQ
Woodbury, MN, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

InSitu Biologics is an emerging biotech company dedicated to developing a multi-phase, prolonged-release drug delivery platform aimed at localized treatment of pain, cancer, and infection. Their innovative solutions focus on providing extended-release treatments, which represent a significant opportunity in the multi-billion dollar healthcare market. The company is currently in the investigational pre-clinical stage, with products not yet available for sale.

InSitu Biologics has made notable strides, including a license agreement with the Mayo Clinic, underscoring its potential impact in the biotech industry. The company's approach to drug delivery aims to revolutionize localized treatment methods, potentially improving patient outcomes and reducing systemic side effects.

InSitu Biologics - Similar Companies

Extend Biosciences logo

Extend Biosciences

extendbio.com

Enable Therapeutics logo

Enable Therapeutics

Sonoran Biosciences logo

Sonoran Biosciences

Portal Instruments logo

Portal Instruments

Surf Bio logo

Surf Bio

surf.bio

InSyBio logo

InSyBio

insybio.gr

Syntis Bio logo

Syntis Bio

syntis.bio

Moat Biotechnology logo

Moat Biotechnology

SpringLeaf Therapeutics logo

SpringLeaf Therapeutics

Micron Biomedical logo

Micron Biomedical

Inception Sciences logo

Inception Sciences

Artizan Biosciences logo

Artizan Biosciences

Incube Labs logo

Incube Labs

incubelabs.com

Bioincept logo

Bioincept

bioincept.com

Direct Biologics logo

Direct Biologics

InSitu Biologics - Quick Facts

Who are InSitu Biologics' competitors?

Companies similar to InSitu Biologics include Extend Biosciences, Enable Therapeutics, Sonoran Biosciences and Portal Instruments.

When was InSitu Biologics founded?

InSitu Biologics was founded in 2014.

Where is InSitu Biologics' headquarters located?

InSitu Biologics' headquarters is located in Woodbury, MN, US.

When was InSitu Biologics' last funding round?

InSitu Biologics' most recent funding round was for $5M (USD) in February 2021.

How much has InSitu Biologics raised to-date?

As of Feb 24, 2021, InSitu Biologics has raised a total of $7M (USD).

How many employees does InSitu Biologics have?

InSitu Biologics has 13 employees as of Feb 5, 2024.

InSitu Biologics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Software
Main Product
  • Drug Delivery
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research